GLP-1 Weight Loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. In simple terms, it mimics a naturally occurring hormone in the body called GLP-1, which is released from the gut after eating. By activating GLP-1 receptors, semaglutide orchestrates a multi-faceted approach to metabolic control. Tirzepatide represents a newer class of medication, acting as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. This means it mimics two different incretin hormones involved in blood sugar regulation. It helps your body feel fuller faster—and stay that way—so you naturally eat less and burn more fat.

Most patients start noticing weight loss within the first 4–6 weeks, with more visible changes between 8–12 weeks. Results vary based on your diet, movement, and baseline weight—but Zepbound® and compounded tirzepatide consistently outperform other medications in clinical studies.

Yes—when prescribed and monitored by a licensed provider. GLP-1s are FDA-approved for weight management and backed by extensive clinical research. Most side effects are mild, such as nausea or fatigue, and typically subside after the first few doses.

GLP-1s work on their own, but results are better when paired with light movement, increased protein intake, and reduced alcohol. No crash diets or high-intensity workouts required—we'll help you build sustainable habits.

Yes. The $695 or $795monthly fee includes everything: your prescription, the medication itself, and all consultations and ongoing provider support. You will pay us directly for the medication and syringes, and we coordinate everything for you — from prescription setup to fulfillment — using trusted, licensed partners to ensure a seamless experience.

Once you've lost the weight, we'll guide you through dose tapering or maintenance, depending on your progress and comfort. The goal is long-term fat loss—not a rebound effect. Every plan is tailored to your body and goals.